TikTok is full of ADHD advice, but nearly half of it is misleading, study finds The study explored TikTok's role as an educational tool for ADHD.

EndeavorOTC is Akili's second digital ADHD therapeutic product to receive FDA authorization, and is the only FDA-authorized digital therapeutic for ADHD available without a prescription, the ...

Akili, which makes a video game treatment for ADHD, will merge with Virtual Therapeutics to create a larger digital health entity.

Akili, which makes a video game treatment for ADHD, will merge with Virtual Therapeutics to create a larger digital health company.

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The ...

Top executives at therapeutic video game maker Akili got significantly less in total compensation in 2023 compared to the year before as the company underwent a leadership shakeup.

Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan ...

Akili, Inc., the leading digital medicine company behind EndeavorOTC™, today released results from a new study examining the ways in which ADHD impacts the U.S. workforce. Akili engaged ...

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that EndeavorOTC™, the mobile video game treatment clinically proven to improve attention and focus in adults with ADHD, ...

Akili executives said a focus on non-prescription digital therapies removes the barriers payers place on access and creates a more sustainable business.

Akili's move from prescription to OTC sales for its ADHD therapy signifies a major shift in digital therapeutics industry. Company also announced layoffs.